VACCINEX, INC. Earnings Per Share Diluted

Quick Answer

VACCINEX, INC. reported Earnings Per Share Diluted of $8.88 (loss) per share for the year ending 2024.

  • VACCINEX, INC. showed an increase of +79.7% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from VACCINEX, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
  • XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2021 to 2024), VACCINEX, INC.'s Earnings Per Share Diluted has declined by 1,038.5%.
  • Historical annual values: Fiscal year 2024: $8.88 (loss) per share | Fiscal year 2023: $43.68 (loss) per share | Fiscal year 2022: $98.05 (loss) per share | Fiscal year 2021: $0.78 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: